Depomed Announces Fourth Quarter and Full Year 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Depomed (DEPO) Tops Q4 EPS by 5c
February 27, 2018 4:04 PM ESTDepomed (NASDAQ: DEPO) reported Q4 EPS of $0.15, $0.05 better than the analyst estimate of $0.10. Revenue for the quarter came in at $94 million versus the consensus estimate of $90.94 million.
For earnings history and earnings-related data on Depomed (DEPO) click here.
... More